Among the gut hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypetide (GIP), referred to as incretins, have gained enormous attention due to their insulinotropic action and relevance in the treatment of type 2 diabetes (T2D) (15). This evidence concerns the gene GCG and type 2 diabetes mellitus.